National Institute of Arthritis and Musculoskeletal and Skin Diseases, National Institutes of Health, Bethesda, MD 20892;
Inflammatory Disease Section, National Human Genome Research Institute, National Institutes of Health, Bethesda, MD 20892.
Proc Natl Acad Sci U S A. 2020 Jan 7;117(1):552-562. doi: 10.1073/pnas.1906593116. Epub 2019 Dec 23.
Systemic sclerosis (SSc) is a clinically heterogeneous autoimmune disease characterized by mutually exclusive autoantibodies directed against distinct nuclear antigens. We examined associations in SSc and its autoantibody subsets in a large, newly recruited African American (AA) cohort and among European Americans (EA). In the AA population, the African ancestry-predominant * and * alleles were associated with overall SSc risk, and the * allele was strongly associated with the severe antifibrillarin (AFA) antibody subset of SSc (odds ratio = 7.4). These African ancestry-predominant alleles may help explain the increased frequency and severity of SSc among the AA population. In the EA population, the * and * alleles were more strongly associated with antitopoisomerase (ATA) and anticentromere antibody-positive subsets of SSc, respectively, than with overall SSc risk, emphasizing the importance of in defining autoantibody subtypes. The association of the * allele with the ATA subset of SSc in both AA and EA patients demonstrated a transancestry effect. A direct correlation between SSc prevalence and * allele frequency in multiple populations was observed ( = 0.98, = 3 × 10). Conditional analysis in the autoantibody subsets of SSc revealed several associated amino acid residues, mostly in the peptide-binding groove of the class II HLA molecules. Using HLA α/β allelic heterodimers, we bioinformatically predicted immunodominant peptides of topoisomerase 1, fibrillarin, and centromere protein A and discovered that they are homologous to viral protein sequences from the Mimiviridae and Phycodnaviridae families. Taken together, these data suggest a possible link between alleles, autoantibodies, and environmental triggers in the pathogenesis of SSc.
系统性硬化症(SSc)是一种具有临床异质性的自身免疫性疾病,其特征是针对不同核抗原的相互排斥的自身抗体。我们在一个新招募的大型非裔美国人(AA)队列和欧洲裔美国人(EA)中检查了 SSc 及其自身抗体亚群的关联。在 AA 人群中,非洲血统为主导的和等位基因与总体 SSc 风险相关,等位基因与严重抗纤维蛋白(AFA)抗体亚群的 SSc 强烈相关(比值比= 7.4)。这些以非洲血统为主导的等位基因可能有助于解释 AA 人群中 SSc 的频率和严重程度增加的原因。在 EA 人群中,和等位基因分别与抗拓扑异构酶(ATA)和抗着丝粒抗体阳性的 SSc 亚群更密切相关,而与总体 SSc 风险相关度较低,强调了在定义自身抗体亚型方面的重要性。在 AA 和 EA 患者中,等位基因与 ATA 亚群的 SSc 的关联表明存在跨种族效应。在多个人群中观察到 SSc 的患病率与等位基因频率之间存在直接相关性(= 0.98,= 3 × 10)。在 SSc 的自身抗体亚群中进行条件分析揭示了几个相关的氨基酸残基,主要位于 II 类 HLA 分子的肽结合槽中。使用 HLA α/β等位基因异二聚体,我们从生物信息学上预测了拓扑异构酶 1、纤维蛋白和着丝粒蛋白 A 的免疫显性肽,并发现它们与 Mimiviridae 和 Phycodnaviridae 家族的病毒蛋白序列同源。综上所述,这些数据表明等位基因、自身抗体和环境触发因素之间可能存在联系,这可能在 SSc 的发病机制中起作用。